Skip to main content

Peer Review reports

From: Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: integrated study of three prospective multicenter phase II trials

Original Submission
28 Apr 2021 Submitted Original manuscript
23 May 2021 Reviewed Reviewer Report
26 May 2021 Reviewed Reviewer Report
29 May 2021 Author responded Author comments - Hirotoshi Iihara
Resubmission - Version 2
29 May 2021 Submitted Manuscript version 2
6 Jun 2021 Reviewed Reviewer Report
6 Jun 2021 Reviewed Reviewer Report
9 Jun 2021 Author responded Author comments - Hirotoshi Iihara
Resubmission - Version 3
9 Jun 2021 Submitted Manuscript version 3
Publishing
8 Jul 2021 Editorially accepted
19 Jul 2021 Article published 10.1186/s12885-021-08572-3

You can find further information about peer review here.

Back to article page